Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Meeting ID

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Dec 04, 2024 12:35pm

175 Views

Post# 36345428

RE:RE:RE:RE:RE:Meeting ID

Thank you feedman and kayz. Good to hear it's only formatting and not the actual data itself. To raise any more money till the FDA decision is made, they might need to release an NR about actually submitting the formal BTD application. Immunity Bio did. They cannot share it with potential PP investors on an exclusive basis, IMO.

<< Previous

Bullboard Posts

Next >>

They started in video game investing, now they serve high net worth traders